# Cerebrolysin for Alzheimer's: meta-analysis of 6 trials

Source: https://pepvault.app/research/cerebrolysin-gauthier-2015

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Meta-analysis · people

# Cerebrolysin beat placebo on global change in Alzheimer's at 6 months

Checked against the paper November 2026 Meta-analysis [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In pooled placebo-controlled trials, Cerebrolysin improved overall clinical ratings in mild-to-moderate Alzheimer's with safety similar to placebo, though its effect on cognition alone was clear only at 4 weeks.

- **Kind:** Meta-analysis
- **Studied in:** People
- **Published:** 2015
- **Journal:** Dement Geriatr Cogn Disord

## What they tested

The team set out to measure the benefits and risks of Cerebrolysin in people with mild-to-moderate Alzheimer's disease by pooling all randomized, double-blind, placebo-controlled trials, while avoiding flaws of an earlier meta-analysis.

## How the study was done

A meta-analysis, which pools results from several studies, of 6 randomized, double-blind trials that compared Cerebrolysin at 30 ml/day with placebo (a dummy treatment) in people with mild-to-moderate Alzheimer's disease. The pooled data covered results at 4 weeks and 6 months, and drew on individual patient data, published group results or both.

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Cerebrolysin did better than placebo on cognitive function at 4 weeks (standardized mean difference -0.40; 95% CI -0.66 to -0.13), but the gap at 6 months (-0.37; 95% CI -0.90 to 0.16) was not statistically significant. On global clinical change, an overall rating of how a patient was doing, the odds of improving favored Cerebrolysin at both 4 weeks (odds ratio 3.32) and 6 months (odds ratio 4.98). A combined measure of global change plus cognition also favored Cerebrolysin at both time points (Mann-Whitney 0.57 each time). Side effects and other safety measures were similar to placebo.

## What it doesn’t show

The pooled results cover two time points, 4 weeks and 6 months, and mix individual patient data with published group results across 6 trials. The cognitive benefit seen at 4 weeks was not statistically significant at 6 months.

## The paper

Gauthier et al. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials. Dement Geriatr Cogn Disord. 2015.

- [PubMed (PMID 25832905)](https://pubmed.ncbi.nlm.nih.gov/25832905/)
- [The paper (DOI 10.1159/000377672)](https://doi.org/10.1159/000377672)

## The compound

- [Cerebrolysin: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016)
- [All 4 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## More studies on Cerebrolysin

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018) Meta-analysis · people · 2018
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016) Randomized trial · people · 2016
- [Cerebrolysin: no overall benefit in acute ischemic stroke at 90 days](https://pepvault.app/research/cerebrolysin-heiss-2012) Randomized trial · people · 2012
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Cerebrolysin

- [Cerebrolysin: the full reference](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)

### Studies

- [Cerebrolysin: better NIHSS scores after stroke across nine trials](https://pepvault.app/research/cerebrolysin-bornstein-2018)
- [Cerebrolysin: better arm function at day 90 after stroke in CARS](https://pepvault.app/research/cerebrolysin-cars-2016)
- [All 4 studies](https://pepvault.app/research#cerebrolysin)

### Compared with

- [Semax vs Cerebrolysin](https://pepvault.app/peptides/compare/semax-vs-cerebrolysin)

### Tools

- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

<!--promo-->

PepVault for iPhone

## Taking cerebrolysin? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Cerebrolysin](https://pepvault.app/research#cerebrolysin)

## The library

- [Cerebrolysin](https://pepvault.app/peptides/cerebrolysin)
- [Cerebrolysin dose guide](https://pepvault.app/lab/dosage/cerebrolysin)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
